These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2143656)

  • 1. Chemical modification of adenosine A1 receptors. Implications for the interaction with R-PIA, DPCPX and amiloride.
    Garritsen A; Ijzerman AP; Beukers MW; Soudijn W
    Biochem Pharmacol; 1990 Aug; 40(4):835-42. PubMed ID: 2143656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain.
    Garritsen A; Ijzerman AP; Beukers MW; Cragoe EJ; Soudijn W
    Biochem Pharmacol; 1990 Aug; 40(4):827-34. PubMed ID: 2143655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of A1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site.
    Klotz KN; Lohse MJ; Schwabe U
    J Biol Chem; 1988 Nov; 263(33):17522-6. PubMed ID: 3182861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of inhibitory effects of zinc and cadmium ions on agonist binding to adenosine A1 receptors in rat brain.
    Rosati AM; Traversa U
    Biochem Pharmacol; 1999 Aug; 58(4):623-32. PubMed ID: 10413299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of histidine residues in agonist and antagonist binding sites of A1 adenosine receptor.
    Allende G; Casadó V; Mallol J; Franco R; Lluis C; Canela EI
    J Neurochem; 1993 Apr; 60(4):1525-33. PubMed ID: 8455039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of interaction of amiloride and some of its analogues with the adenosine A1 receptor.
    Garritsen A; Beukers MW; IJzerman AP; Cragoe EJ; Soudijn W
    Neurochem Int; 1992 Feb; 20(2):207-13. PubMed ID: 1304860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the high affinity binding site for [3H]-1,3-dipropyl-8-cyclopentylxanthine in frog brain membranes.
    Oliveira JC; Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1993 Jun; 109(2):518-23. PubMed ID: 8358551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine nucleotide effects on 8-cyclopentyl-1,3-[3H]dipropylxanthine binding to membrane-bound and solubilized A1 adenosine receptors of rat brain.
    Klotz KN; Keil R; Zimmer FJ; Schwabe U
    J Neurochem; 1990 Jun; 54(6):1988-94. PubMed ID: 2338552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
    Gerwins P; Nordstedt C; Fredholm BB
    Mol Pharmacol; 1990 Nov; 38(5):660-6. PubMed ID: 2172773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic visualization of A1 adenosine receptors in rat brain with [3H]8-cyclopentyl-1,3-dipropylxanthine.
    Weber RG; Jones CR; Lohse MJ; Palacios JM
    J Neurochem; 1990 Apr; 54(4):1344-53. PubMed ID: 2313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.
    Peachey JA; Hourani SM; Kitchen I
    Br J Pharmacol; 1994 Dec; 113(4):1249-56. PubMed ID: 7889280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.
    Finlayson K; Maemoto T; Butcher SP; Sharkey J; Olverman HJ
    Acta Pharmacol Sin; 2003 Aug; 24(8):729-40. PubMed ID: 12904270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.
    Mazzoni MR; Buffoni RS; Giusti L; Lucacchini A
    J Recept Signal Transduct Res; 1995; 15(7-8):905-29. PubMed ID: 8673723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.
    Jacobson KA; Stiles GL; Ji XD
    Mol Pharmacol; 1992 Jul; 42(1):123-33. PubMed ID: 1635550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.
    Gao ZG; Melman N; Erdmann A; Kim SG; Müller CE; IJzerman AP; Jacobson KA
    Biochem Pharmacol; 2003 Feb; 65(4):525-34. PubMed ID: 12566079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of urea pretreatment on the binding properties of adenosine A1 receptors.
    May LT; Sexton PM; Christopoulos A
    Br J Pharmacol; 2005 Dec; 146(8):1119-29. PubMed ID: 16231004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of adenosine agonists and antagonists in rat hippocampal neurons.
    Ameri A; Jurna I
    Brain Res; 1991 Apr; 546(1):69-78. PubMed ID: 1855150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
    Choca JI; Proudfit HK; Green RD
    J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.